Advertisement

Theoretischer Hintergrund

Chapter
  • 1.9k Downloads

Zusammenfassung

Ursprünglich wurde die Gruppe der Schizophrenien als eine chronische Erkrankung betrachtet, die einen unaufhaltsam progressiven Verlauf nimmt (Kraepelin 1913). Die Recovery-Bewegung und empirische Ergebnisse wirken jedoch diesem Stigma der Unheilbarkeit entgegen. So wird zum Beispiel bei der Recovery-Bewegung durch eine ganzheitliche Betrachtungsweise des Menschen die Möglichkeit betont, krankheitsbedingte Beeinträchtigungen zu überwinden und trotz der Diagnose einer Schizophrenie ein selbstbestimmtes und sinnerfülltes Leben zu führen (Amering u. Schmolke 2009). Recovery ist heute in vielen Ländern gesundheitspolitische Vorgabe für den Bereich der Gesundheitsförderung und der psychiatrischen Versorgung. Unterstützt wird dies durch die Ergebnisse mehrerer Langzeitverlaufsstudien, in denen sich unerwartet hohe Recovery-Raten zwischen 25 % und 65 % ergaben (Rabinowitz et al. 2007; Davidson et al. 2008). Für den Begriff „Recovery“, der übersetzt Gesundung bedeutet, existiert bislang jedoch noch keine einheitliche Definition. Das Recovery-Konzept wurde von verschiedenen Richtungen geprägt und unterschiedlich konzeptualisiert.

Literatur

  1. Addington J, Saeedi H, Addington D (2006) Facial affect recognition: a mediator between cognitive and social functioning in psychosis. Schizophrenia Research 85(1–3):142–150PubMedCrossRefGoogle Scholar
  2. Aleman A, Agrawal N, Morgan KD, Davis AS (2006) Insight in psychosis and neuropsychological function. British Journal of Psychiatry 189:204–212PubMedCrossRefGoogle Scholar
  3. Amering M, Schmolke M (2009) Recovery in mental health. Reshaping scientific and clinical responsibilities. Wiley-Blackwell, LondonCrossRefGoogle Scholar
  4. Andreasen NC, Carpenter WTJ, Kane JM, Lasser RA, Marder SR, Weinberger DR (2005) Remission in Schizophrenia: Proposed criteria and rationale for consensus. American Journal of Psychiatry 162:441–449PubMedCrossRefGoogle Scholar
  5. Barch DM, Keefe RS (2010) Anticipating DSM-V: opportunities and challenges for cognition and psychosis. Schizophrenia Bulletin 36(1):43–47PubMedCrossRefGoogle Scholar
  6. Becker HE, Nieman DH, Wiltink S, Dingemans PM, van de Fliert L, van Amelsvoort TA, Linszen DH (2010) Neurocognitive functioning before and after the first psychotic episode: does psychosis result in cognitive deterioration? Psychological Medicine 40:1599–1606PubMedCrossRefGoogle Scholar
  7. Bellack AS, Green MF, Cook JA, Fenton W, Harvey PW, Heaton RK, Laughren T, Leon AC, Mayo DJ, Patrick DL, Patterson TL, Rose A, Stover E, Wykes T (2007) Assessment of Community Functioning in People With Schizophrenia and Other Severe Mental Illnesses: A White Paper Based on an NIMH-Sponsored Workshop. Schizophrenia Bulletin 33:805–822PubMedCrossRefGoogle Scholar
  8. Bertrand MC, Sutton H, Achim AM, Malla AK, Lepage M (2007) Social cognitive impairments in first episode psychosis. Schizophrenia Research 95:124–133PubMedCrossRefGoogle Scholar
  9. Bhojraj T, Francis A, Montrose DM, Keshavan MS (2011) Grey matter and cognitive deficits in young relatives of schizophrenia patients. NeuroImage 54(1):287–292CrossRefGoogle Scholar
  10. Bleuler E (1911) Dementia Praecox oder die Gruppe der Schizophrenien. Deuticke, LeipzigGoogle Scholar
  11. Bora E, Yucel M, Pantelis C (2009) Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives. Journal of Affective Disorders 113:1–20PubMedCrossRefGoogle Scholar
  12. Bottlender R, Strauß A, Möller H-J (2010) Social disability in schizophrenic, schizoaffective and affective disorders 15 years after admission. Schizophrenia Research 116:9–15PubMedCrossRefGoogle Scholar
  13. Bowie CR, Harvey PD (2005) Cognition in schizophrenia: impairments, determinants, and functional importance. Psychiatric Clinics of North America 28:613–633PubMedCrossRefGoogle Scholar
  14. Bowie CR, Depp C, McGrath JA, Wolyniec P, Mausbach BT, Thornquist MH, Luke J, Patterson TL, Harvey PD, Pulver AE (2010) Prediction of real-world functional disability in chronic mental disorders: A comparison of schizophrenia and bipolar disorder. American Journal of Psychiatry 167(9):1116–1124PubMedCrossRefGoogle Scholar
  15. Bowie CR, Reichenberg A, Patterson TL, Heaton BK, Havey PD (2006) Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms. American Journal of Psychiatry 163:418–425PubMedCrossRefGoogle Scholar
  16. Brekke J, Nakagami E et al (2010) The relevance of neurocognition and social cognition for outcome and recovery in schizophrenia. In: Roder V, Medalia A (Hrsg) Neurocognition and social cognition in schizophrenia patients. Comprehension and treatment. Karger, Basel, S. 23–36CrossRefGoogle Scholar
  17. Brenner HD, Stramke WG, Mewes J, Liese F, Seeger G (1980) Erfahrungen mit einem spezifischen Therapieprogramm zum Training kognitiver und kommunikativer Fahigkeiten in der Rehabilitation chronisch schizophrener Patienten. Nervenarzt 51:106–112PubMedGoogle Scholar
  18. Brothers L (1990) The social brain: A project for integrating primate behavior and neurophysiology in a new domain. Concepts in Neuroscience 1:27–51Google Scholar
  19. Brüne M, Abdel-Hamid M, Lehmkämper C, Sonntag C (2007) Mental state attribution, neurocognitive functioning, and psychopathology: What predicts poor social competence in schizophrenia best? Schizophrenia Research 92:151–159PubMedCrossRefGoogle Scholar
  20. Brunet-Gouet E, Decety J (2006) Social brain dysfunctions in schizophrenia: A review of neuroimaging studies. Psychiatry Research 148(2-3):75–92PubMedCrossRefGoogle Scholar
  21. Buchanan RW, Keefe RS, Umbricht D, Green MF, Laughren T, Marder SR (2011) The FDA-NIMH-MATRICS guidelines for clinical trial design of cognitive-enhancing drugs: what do we know 5 years later? Schizophrenia Bulletin 37(6):1209–1217PubMedCrossRefGoogle Scholar
  22. Buss A, Lang P (1965) Psychological deficit in schizophrenia: Affect reinforcement and concept attainment. Journal of Abnormal Psychology 70:2–24PubMedCrossRefGoogle Scholar
  23. Carrión RE, Goldberg TE, McLaughlin D, Auther AM, Correll CU, Cornblatt BA (2011) Impact of Neurocognition on Social and Role Functioning in Individuals at Clinical High Risk for Psychosis. American Journal of Psychiatry AiA:1–8Google Scholar
  24. Chapman LJ, Chapman JP (1973) Disordered thought in schizophrenia. Prentice Hall, Englewood CliffsGoogle Scholar
  25. Choi J, Medalia A (2010) Intrinsic motivation and learning in a schizophrenia spectrum sample. Schizophrenia Research 118:12–19PubMedCrossRefGoogle Scholar
  26. Cohen AS, Forbes CB, Mann MC, Blanchard JJ (2006) Specific cognitive deficits and differential domains of social functioning in schizophrenia. Schizophrenia Research 81:227–238PubMedCrossRefGoogle Scholar
  27. Couture SM, Penn DL, Roberts DL (2006) The functional significance of social cognition in schizophrenia: A Review. Schizophrenia Bulletin 32:44–63CrossRefGoogle Scholar
  28. Couture SM, Granholm EL, Fish SC (2011) A path model investigation of neurocognition, theory of mind, social competence, negative symptoms and real-world functioning in schizophrenia. Schizophrenia Research 125(2–3):152–160PubMedCrossRefGoogle Scholar
  29. Cromwell RL, Spaulding W (1978) How schizophrenics handle information. In: Fann WE, Karacan I, Pokorny AD, Williams RL (Hrsg) The phenomenology and treatment of schizophrenia. Spectrum, New York, S. 127–162Google Scholar
  30. Davidson L, Schmutte T, Dinzeo T, Andres-Hyman R (2008) Remission and recovery in schizophrenia: Practitioner and patient perspectives. Schizophrenia Bulletin 34:5–8PubMedCrossRefGoogle Scholar
  31. Dickinson D, Ramsey ME, Gold JM (2007) Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. Archives of General Psychiatry 64:532–542PubMedCrossRefGoogle Scholar
  32. Eack SM, Mermon DE, Montrose DM, Miewal J, Gur RE, Gur RC, Sweeney JA, Keshavan MS (2010) Social cognition deficits among individuals at familial high risk for schizophrenia. Schizophrenia Bulletin 36(6):1081–1088PubMedCrossRefGoogle Scholar
  33. Emsley R, Oosthuizen P, Koen L, Niehaus D, Medori R, Rabinowitz J (2008) Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injection. International Clinical Psychopharmacology 23(6):325–331PubMedCrossRefGoogle Scholar
  34. Fett AK, Viechtbauer W, Dominguez MD, Penn DL, van Os J et al (2011) The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: A meta-analysis. Neuroscience u Biobehavioral Review 35:573–588CrossRefGoogle Scholar
  35. Fioravanti M, Carlone O, Vitale B, Cinti ME, Clare L (2005) A meta-analysis of cognitive deficits in adults with a diagnosis of schizophrenia. Neuropsychology Review 15:73–95PubMedCrossRefGoogle Scholar
  36. Foussias G, Remington G (2010) Negative symptoms in schizophrenia: avolition and Occam’s razor. Schizophrenia Bulletin 36(2):359–369PubMedCrossRefGoogle Scholar
  37. Gard DE, Fisher M, Garrett C, Genevsky A, Vinogradov S (2009) Motivation and its relationship to neurocognition, social cognition, and functional outcome in schizophrenia. Schizophrenia Research 115:74–81PubMedCrossRefGoogle Scholar
  38. Gillis JS (1969) Schizophrenic thinking in a probabilistic situation. Psychological Record 19:211–224Google Scholar
  39. Goldberg TE, Berman KF, Mohr E, Weinberger DR (1990) Regional cerebral blood flow and cognitive function in Huntington’s disease and schizophrenia: A comparison of patients matched for performance on a prefrontal-type task. Archives of Neurology 47:418–422PubMedCrossRefGoogle Scholar
  40. Gray JA, Roth BL (2007) Molecular targets for treating cognitive dysfunction in schizophrenia. Schizophrenia Bulletin 33:1100–1119PubMedCrossRefGoogle Scholar
  41. Green MF, Nuechterlein KH (2004) The MATRICS initiative: developing a consensus cognitive battery for clinical trials. Schizophrenia Research 72:1–3PubMedCrossRefGoogle Scholar
  42. Green MF, Kern RS, Braf DL, Mintz J (2000) Neurocognitive Deficits and Functional Outcome in Schizophrenia: Are We Measuring the ″Right Stuff″? Schizophrenia Bulletin 26(1):119–136PubMedCrossRefGoogle Scholar
  43. Green MF, Kern RS, Heaton RK (2004) Longitudinal studies of cognition and functional outcome in schizophrenia: Implications for MATRICS. Schizophrenia Research 72(1):41–51PubMedCrossRefGoogle Scholar
  44. Green MF, Olivier B, Crawley JN, Penn DL, Silverstein S (2005) Social cognition in schizophrenia: Recommendations from the Measurement and Treatment Research to Improve Cognition in Schizophrenia New Approaches Conference. Schizophrenia Research 31:882–887Google Scholar
  45. Green MF, Nuechterlein KH, Kern RS, Baade LE, Fenton WS, Gold JM, Keefe RSE, Mesholam-Gately R, Seidman LJ, Stover E, Marder SR (2008) Functional co-primary measures for clinical trials in schizophrenia: Results from the MATRICS psychometric and standardization study. American Journal of Psychiatry 165(2):221–228PubMedCrossRefGoogle Scholar
  46. Green MF, Schooler MR, Kern RS, Frese FJ, Granberry W, Harvey PD, Karson CN, Peters N, Stewart M, Seidman LJ, Sonnenberg J, Stone WS, Walling D, Stover E, Marder SR (2011) Evaluation of functionally meaningsful measures for clinical trials of cognition enhancement in schizophrenia. American Journal of Psychiatry 168:400–407PubMedCrossRefGoogle Scholar
  47. Häfner H (2005) Das Rätsel Schizophrenie – Eine Krankheit wird entschlüsselt, 3. Aufl. Beck, MünchenGoogle Scholar
  48. Harvey PD, Velligan DI, Bellack AS (2007) Performance-based measures of functional skills: usefulness in clinical treatment studies. Schizophrenia Bulletin 33(5):1138–1148PubMedCrossRefGoogle Scholar
  49. Hemsley DR (1977) What have cognitive deficits to do with schizophrenic symptoms? British Journal of Psychiatry 130:167–173PubMedCrossRefGoogle Scholar
  50. Keefe RSE, Bilder RM, Davis SM, Harvey PD, Green MF, Gold JM, Meltzer HY, Palmer BW et al (2007) Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial. Archives of General Psychiatry 64:633–647PubMedCrossRefGoogle Scholar
  51. Keefe RSE, Fox KH, Harvey PD, Cuchiaro J, Siu C, Loebel A (2011) Characteristics of the MATRICS consensus cognitive battery in a 29-site antiphlogistic schizophrenia clinical trial. Schizophrenia Research 125:161–168PubMedCrossRefGoogle Scholar
  52. Kern RS, Horan WP (2010) Definition and measurement of neurocognition and social cognition. In: Roder V, Medalia A (Hrsg) Neurocognition and social cognition in schizophrenia patients. Comprehension and treatment. Karger, BaselGoogle Scholar
  53. Kern RS, Hartzell AM, Izaguirre B, Hamilton AH (2010) Declarative and non-declarative memory in schizophrenia: What is impaired? What is spared? Journal of Clinical and Experimental Neuropsychology 32:1017–1027PubMedCrossRefGoogle Scholar
  54. Keshavan MS, Kulkarni S, Bhojraj T, Francis A, Diwadkar V, Montrose DM, Seidman LJ, Sweeney J (2010) Premorbid cognitive deficits in young relatives of schizophrenia patients. Frontiers in Human Neuroscience 3(62):1–14Google Scholar
  55. Kirkpatrick B, Fenton W, Carpenter WT, Marder SR (2006) The NIMH-MATRICS consensus statement on negative symptoms. Schizophrenia Bulletin 32:296–303Google Scholar
  56. Krabbendam L, Myin-Germeys I, Bak M, Van Os J (2005) Explaining transitions over the hypothesized psychosis continuum. Australian and New Zealand Journal of Psychiatry 39:180–186PubMedCrossRefGoogle Scholar
  57. Kraepelin E (1913) Psychiatrie. Ein Lehrbuch für Studierende und Ärzte. Barth, Leipzig (3. Band: Klinische Psychiatrie, 2. Teil)Google Scholar
  58. Leifker FR, Patterson TL, Heaton RK, Harvey PD (2011) Validating Measures of Real-World Outcome: The Results of the VALERO Expert Survey and RAND Panel. Schizophrenia Bulletin 37(2):334–343PubMedCrossRefGoogle Scholar
  59. Leucht S, Lasser R (2006) The Concepts of Remission and Recovery in Schizophrenia. Pharmacopsychiatry 39:161–170PubMedCrossRefGoogle Scholar
  60. Mausbach BT, Moore R, Bowie C, Cardenas V, Patterson TL (2009) A review of instruments for measuring functional recovery in those diagnosed with psychosis. Schizophrenia Bulletin 35(2):307–318PubMedCrossRefGoogle Scholar
  61. McGlashan TH (1988) A selective review of recent North American long-term followup studies of schizophrenia. Schizophrenia Bulletin 14(4):515–542PubMedCrossRefGoogle Scholar
  62. Medalia A, Lim RW (2004) Self-awareness of cognitive functioning in schizophrenia. Schizophrenia Research 71:331–338PubMedCrossRefGoogle Scholar
  63. Medalia A, Thysen J, Freilich B (2008) Do people with schizophrenia who have objective cognitive impairments identify cognitive deficits on a self-report measure? Schizophrenia Research 105:156–164PubMedCrossRefGoogle Scholar
  64. Mesholam-Gately RI, Giuliano AJ, Goff KP, Faraone SV, Seidman LJ (2009) Neurocognition in first-episode schizophrenia: a meta-analytic review. Neuropsychology 23:315–336PubMedCrossRefGoogle Scholar
  65. Milev P, Ho BC, Arndt S, Andreasen NC (2005) Predictive values of neurocognition and negatvie symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. American Journal of Psychiatry 162:495–506PubMedCrossRefGoogle Scholar
  66. Mueller DR, Roder V (2005) Social skills training in recreational rehabilitation of schizophrenia patients. American Journal of Recreation Therapy 4(3):11–19Google Scholar
  67. Mueller DR, Roder V, Brenner HD (2007) Effektivität des Integrierten Psychologischen Therapieprogramms (IPT). Eine Meta-Analyse über 28 unabhängige Studien. Nervenarzt 78(1):62–73CrossRefGoogle Scholar
  68. Mueller DR, Schmidt SJ, Roder V (in press) Integrated Neurocognitive Therapy (INT). In: Penn DL, Roberts D (Hrsg) Social cognition in schizophrenia. Elsevier, New YorkGoogle Scholar
  69. Murray CJL, Lopez AD (1996) Evidence-Based Health Policy: Lessons from the Global Burden of Disease Study. Science 274(5288):740–743PubMedCrossRefGoogle Scholar
  70. Nasrallah HA, Targum SD, Tandon R, McCombs JS, Ross R (2005) Defining and Measuring Clinical Effectiveness in the Treatment of Schizophrenia. Psychiatric Services 56:273–282PubMedCrossRefGoogle Scholar
  71. Niendam TA, Bearden CE, Rosso IM, Sanchez LE, Hadley T, Nuechterlein KH, Cannon TD (2003) A prospective study of childhood neurocognitive functioning in schizophrenic patients and their siblings. American Journal of Psychiatry 160(11):2060–2062PubMedCrossRefGoogle Scholar
  72. Nuechterlein KH, Dawson ME, Green MF (1994) Information-processing abnormalities as neuropsychological vulnerability indicators for schizophrenia. Acta Psychiatrica Scandinavica/Supplementum 384:71–79CrossRefGoogle Scholar
  73. Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton TE (2004) Identification of separable cognitive factors in schizophrenia. Schizophrenia Research 72:29–39PubMedCrossRefGoogle Scholar
  74. van Os J, Burns T, Cavallaro R, Leucht S, Peuskens J, Helldin L, Bernardo M, Arango C, Fleischhacker W, Lachaux B, Kane JM (2006) Standardized remission criteria in schizophrenia. Acta Psychiatrica Scandinavica 113:91–95PubMedCrossRefGoogle Scholar
  75. Osler M, Lawlor DA, Nordentoft M (2007) Cognitive function in childhood and early adulthood and hospital admission for schizophrenia and bipolar disorders in Danish men born in 1953. Schizophrenia Research 92(1–3):132–141PubMedCrossRefGoogle Scholar
  76. Palmer BW, Dawes SE, Heaton RK (2009) What do we know about neuropsychological aspects of schizophrenia? Neuropsychology Review 19(3):365–384PubMedCrossRefGoogle Scholar
  77. Penn DL, Corrigan PW, Bentall RP, Racenstein JM, Newman L (1997) Social cognition in schizophrenia. Psychological Bulletin 121(1):114–132PubMedCrossRefGoogle Scholar
  78. Penn DL, Addington J, Pinkham A (2006) Social cognitive impairments. In: Lieberman JA, Stroup TS, Perkins DO (Hrsg) The American psychiatric publishing textbook of schizophrenia. American Psychiatric Publishing, Inc., London, S. 261–274Google Scholar
  79. Pinkham AE, Penn DL (2006) Neurocognitive and social cognitive predictors of interpersonal skill in schizophrenia. Psychiatry Research 143:167–178PubMedCrossRefGoogle Scholar
  80. Pinkham AE, Penn DL, Perkins DO, Lieberman J (2003) Implications for the neural basis of social cognition for the study of schizophrenia. American Journal of Psychiatry 160(5):815–824PubMedCrossRefGoogle Scholar
  81. Pinkham AE, Hopfinger JB, Pelphrey KA, Piven J, Penn DL (2008) Neural bases for impaired social cognition in schizophrenia and autism spectrum disorders. Schizophrenia Research 99(1–3):164–175PubMedCrossRefGoogle Scholar
  82. Rabinowitz J, Levine SZ, Haim R, Häfner H (2007) The course of schizophrenia: Progressive deterioration, amelioration or both? Schizophrenia Research 91:254–258PubMedCrossRefGoogle Scholar
  83. Rassovsky Y, Horan WP, Lee J, Sergi MJ, Green MF (2011) Pathways between early visual processing and functional outcome in schizophrenia. Psychological Medicine 41:487–497PubMedCrossRefGoogle Scholar
  84. Resnick S, Fontana A, Lehman AF, Rosenheck R (2005) An empirical conceptualization of the recovery orientation. Schizophrenia Research 75:119–128PubMedCrossRefGoogle Scholar
  85. Roder V, Brenner HD, Kienzle N, Hodel B (1988) Integriertes Psychologisches Therapieprogramm (IPT) für schizophrene Patienten. Psychologie Verlags Union, WeinheimGoogle Scholar
  86. Roder V, Mueller DR, Mueser KT, Brenner HD (2006) Integrated Psychological Therapy (IPT) for Schizophrenia: Is it Effective? Schizophrenia Bulletin 32(1):81–93CrossRefGoogle Scholar
  87. Roder V, Brenner HD, Kienzle N (2008) Integriertes Psychologisches Therapieprogramm bei schizophren Erkrankten IPT. Beltz, WeinheimGoogle Scholar
  88. Roder V, Mueller DR, Brenner HD, Spaulding W (2010) Integrated Psychological Therapy (IPT) for the treatment of neurocognition, social cognition and social competency in schizophrenia patients. Hogrefe u. Huber, Göttingen, SeattleGoogle Scholar
  89. Roder V, Mueller DR, Schmidt SJ (2011) Effectiveness of Integrated Psychological Therapy (INT) for Schizophrenia patients: a research update. Schizophrenia Bulletin 37(2):71–79CrossRefGoogle Scholar
  90. Ruckstuhl U (1981) Schizophrenieforschung. Beltz, WeinheimGoogle Scholar
  91. San L, Ciudad A, Alvarez E, Bobes J, Gilaberte I (2007) Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: prevalence and associations in a cross-sectional study. European Psychiatry 22:490–498PubMedCrossRefGoogle Scholar
  92. Saß H, Wittchen H-U, Zaudig M (Hrsg.) (1994) Diagnostisches und Statistisches Manual Psychischer Störungen (DSM-IV). Hogrefe, GöttingenGoogle Scholar
  93. Schmidt S, Mueller DR, Roder V (2011) Social Cognition as a Mediator Variable Between Neurocognition and Functional Outcome in Schizophrenia: Empirical Review and New Results by Structural Equation Modeling. Schizophrenia Bulletin 37(2):41–54CrossRefGoogle Scholar
  94. Seidman LJ, Giuliano AJAJ, Meyer EC, Addington J, Cadenhead KS, Cannon TD, Mcglashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, Bearden CE, Christensen BK, Hawkins K, Heaton R, Keefe RS, Heinssen R, Cornblatt BA (2010) Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis. Archives of General Psychiatry 67:578–588PubMedCrossRefGoogle Scholar
  95. Sergi MJ, Rassovsky Y, Widmark C, Reist C, Erhart S, Braff DL, Marder SR, Green MF (2007) Social cognition in schizophrenia: relationships with neurocognition and negative symptoms. Schizophrenia Research 90:316–324PubMedCrossRefGoogle Scholar
  96. Shrivastava A, Johnston M, Shah N, Bureau Y (2010) Redefining outcome measures in schizophrenia: integrating social and clinical parameters. Current Opinion in Psychiatry 23:120–126PubMedCrossRefGoogle Scholar
  97. Sibitz I, Amering M, Unger A, Seyringer ME, Bachmann A, Schrank B, Benesch T, Schulze B, Woppmann A (2011) The impact of the social network, stigma and empowerment on the quality of life in patients with schizophrenia. European Psychiatry 26(1):28–33PubMedCrossRefGoogle Scholar
  98. Strik W, Schmidt SJ, Roder V (2012) Cognition and schizophrenia. In: Pallanti S, Lauriello J (Hrsg) Clinical manual of schizophrenia. American. Psychiatric Publishing, Arlington, VAGoogle Scholar
  99. Velligan DI, Kern RS, Gold JM (2006) Cognitive rehabilitation for schizophrenia and the putative role of motivation and expectancies. Schizophrenia Bulletin 32:474–485PubMedCrossRefGoogle Scholar
  100. Ventura J, Hellemann GS, Thames AD, Koellner V, Nuechterlein KH (2009) Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia. Schizophrenia Research 113:189–199PubMedCrossRefGoogle Scholar
  101. Ventura J, Reise SP, Keefe R, Baade LE, Gold JM, Green MF, Kern RS, Mesholam-Gately R, Nuechterlein KH, Seidman LJ, Bilder RM (2010) The Cognitive Assessment Interview (CAI): Development and validation of an empirically derived, brief interview-based measure of cognition. Schizophrenia Research 121:24–31PubMedCrossRefGoogle Scholar
  102. Woodberry KA, Seidman LJ, Giuliano AJ, Verdi MB, Cook WL, McFarlane WR (2010) Neuropsychological profiles in individuals at clinical high risk for psychosis: Relationship to psychosis and intelligence. Schizophrenia Research 123:188–198PubMedCrossRefGoogle Scholar
  103. Wykes T, van der Gaag M (2001) Is it time to develop a new cognitive therapy for psychosis cognitive remediation therapy (CRT)? Clinical Psychology Review 21(8):1227–1256PubMedCrossRefGoogle Scholar
  104. Wykes T, Reeder C (2005) Cognitive Remediation Therapy for Schizophrenia. Routledge, London, New YorkGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  1. 1.Universitätsklinik und Poliklinik für PsychiatrieUniversität BernBernSchweiz
  2. 2.Universitätsklinik und Poliklinik für PsychiatrieUniversität BernBernSchweiz

Personalised recommendations